Literature DB >> 30019153

CXCL13 polymorphism is associated with essential hypertension in Tatars from Russia.

Yanina R Timasheva1,2, Timur R Nasibullin3, Ilsiyar A Tuktarova3, Vera V Erdman3, Olga E Mustafina3,4.   

Abstract

Essential arterial hypertension is a disease with distinct yet unexplored inflammatory component. Our aim was to assess the role of chemokine genes and their interaction in its development. Genotyping of polymorphic markers in six chemokine genes (CXCL13, CCL8, CCL16, CCL17, CCL18, and CCL23) was performed in the group of 522 men of Tatar ethnic origin from the Republic of Bashkortostan, Russia (213 patients with essential hypertension and 309 healthy individuals without history of cardiovascular disease). We found a strong association of CXCL13 rs355689*C allele with essential hypertension under additive (OR 0.56, PFDR = 0.008) and dominant (OR 0.41, PFDR 4.38 × 10- 4) genetic model. The analysis of gene-gene interactions revealed 12 allele/genotype combinations that remained significantly associated with essential hypertension after correction for multiple testing was applied, and each of these combinations included CXCL13 rs355689 polymorphism. Our results indicate that CXCL13 rs355689 polymorphism is strongly associated with essential hypertension in the ethnic group of Tatars, alone and in combination with polymorphic markers in other chemokine genes.

Entities:  

Keywords:  Chemokines; Essential hypertension; Genetic testing; Risk prediction

Mesh:

Substances:

Year:  2018        PMID: 30019153     DOI: 10.1007/s11033-018-4257-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

1.  Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia.

Authors:  Marco Tucci; Cosima Quatraro; Maria Antonia Frassanito; Franco Silvestris
Journal:  J Hypertens       Date:  2006-07       Impact factor: 4.844

2.  High serum levels of CXC chemokine ligand 10 in untreated essential hypertension.

Authors:  A Antonelli; P Fallahi; M Rotondi; S M Ferrari; P Romagnani; L Ghiadoni; M Serio; S Taddei; E Ferrannini
Journal:  J Hum Hypertens       Date:  2008-03-13       Impact factor: 3.012

3.  CCL23 expression is induced by IL-4 in a STAT6-dependent fashion.

Authors:  Hermann Novak; Anke Müller; Nathalie Harrer; Claudia Günther; Jose M Carballido; Maximilian Woisetschläger
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

4.  Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis.

Authors:  Daniela Galimberti; Diego Scalabrini; Chiara Fenoglio; Milena De Riz; Cristoforo Comi; Eliana Venturelli; Francesca Cortini; Mirko Piola; Maurizio Leone; Umberto Dianzani; Sandra D'Alfonso; Francesco Monaco; Nereo Bresolin; Elio Scarpini
Journal:  J Neurol Sci       Date:  2007-10-29       Impact factor: 3.181

5.  CCL genes in multiple sclerosis and systemic lupus erythematosus.

Authors:  Tamara Vyshkina; Andrew Sylvester; Saud Sadiq; Eduardo Bonilla; Andras Perl; Bernadette Kalman
Journal:  J Neuroimmunol       Date:  2008-07-03       Impact factor: 3.478

6.  Phospholipase C-β3 is a key modulator of IL-8 expression in cystic fibrosis bronchial epithelial cells.

Authors:  Valentino Bezzerri; Pio d'Adamo; Alessandro Rimessi; Carmen Lanzara; Sergio Crovella; Elena Nicolis; Anna Tamanini; Emmanouil Athanasakis; Maela Tebon; Giulia Bisoffi; Mitchell L Drumm; Michael R Knowles; Paolo Pinton; Paolo Gasparini; Giorgio Berton; Giulio Cabrini
Journal:  J Immunol       Date:  2011-03-16       Impact factor: 5.422

7.  CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.

Authors:  Markus C Kowarik; Sabine Cepok; Johann Sellner; Verena Grummel; Martin S Weber; Thomas Korn; Achim Berthele; Bernhard Hemmer
Journal:  J Neuroinflammation       Date:  2012-05-16       Impact factor: 8.322

Review 8.  The chemokine and chemokine receptor superfamilies and their molecular evolution.

Authors:  Albert Zlotnik; Osamu Yoshie; Hisayuki Nomiyama
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

9.  Connecting genetic risk to disease end points through the human blood plasma proteome.

Authors:  Karsten Suhre; Matthias Arnold; Aditya Mukund Bhagwat; Richard J Cotton; Rudolf Engelke; Johannes Raffler; Hina Sarwath; Gaurav Thareja; Annika Wahl; Robert Kirk DeLisle; Larry Gold; Marija Pezer; Gordan Lauc; Mohammed A El-Din Selim; Dennis O Mook-Kanamori; Eman K Al-Dous; Yasmin A Mohamoud; Joel Malek; Konstantin Strauch; Harald Grallert; Annette Peters; Gabi Kastenmüller; Christian Gieger; Johannes Graumann
Journal:  Nat Commun       Date:  2017-02-27       Impact factor: 14.919

10.  Genetic and Pharmacologic Inhibition of the Chemokine Receptor CXCR2 Prevents Experimental Hypertension and Vascular Dysfunction.

Authors:  Lei Wang; Xue-Chen Zhao; Wei Cui; Yong-Qiang Ma; Hua-Liang Ren; Xin Zhou; John Fassett; Yan-Zong Yang; Yingjie Chen; Yun-Long Xia; Jie Du; Hui-Hua Li
Journal:  Circulation       Date:  2016-09-27       Impact factor: 29.690

View more
  2 in total

1.  The Relationship Between Chemokine and Chemokine Receptor Genes Polymorphisms and Chronic Obstructive Pulmonary Disease Susceptibility in Tatar Population from Russia: A Case Control Study.

Authors:  Gulnaz F Korytina; Yulia G Aznabaeva; Leysan Z Akhmadishina; Olga V Kochetova; Timur R Nasibullin; Naufal Sh Zagidullin; Shamil Z Zagidullin; Tatyana V Viktorova
Journal:  Biochem Genet       Date:  2021-06-06       Impact factor: 1.890

2.  Whole transcriptome analysis of adrenal glands from prenatal glucocorticoid programmed hypertensive rodents.

Authors:  Sujeenthar Tharmalingam; Sandhya Khurana; Alyssa Murray; Jeremy Lamothe; T C Tai
Journal:  Sci Rep       Date:  2020-10-30       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.